The Kedrab Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The growth trend in the Kedrab Market has been identified as XX (HCAGR) in the past years. The market size, which was at $XX million in 2024, is predicted to increase to $XX million in 2025. The growth rate, compounded annually, is expected to be XX%.
The Kedrab global market is set to grow at a compound annual growth rate (CAGR) of XX% and is predicted to reach a market size of $XX million by 2029.
Download Your Free Sample of the 2025 Kedrab Market Report and Uncover Key Trends Now!Key growth drivers of the kedrab market include:
• Rising prevalence of breast cancer
• Advancements in targeted treatment approaches, such as the pairing of trastuzumab with DM1
• Minimized harm to healthy tissues due to targeted treatment, enhancing effectiveness
• The increase in the number of diagnosed breast cancer cases worldwide.
The kedrab market covered in this report is segmented –
1) By Indication: Post-Exposure Prophylaxis For Rabies, Treatment For Patients Exposed To Suspected Rabid Animals
2) By Formulation: Injectable Formulation, Lyophilized Powder For Reconstitution
3) By Route Of Administration: Intramuscular Injection, Subcutaneous Injection
4) By Distribution Channel: Direct Sales, Wholesalers And Distributors, Retail Pharmacies, Online Pharmacies
5) By End User: Hospitals, Emergency Departments, Specialty Clinics, Public Health Organizations
Market trends in the kedrab market include:
• Combination immunoglobulin therapies are becoming a major trend.
• There is a significant increase in the adoption of Kedrab in the Asia-Pacific region.
• The focus is shifting towards cost-effective treatment solutions.
• The market is potentially impacted by the increasing integration of digital health tools for rabies management.
The top competitors and leading players in the kedrab market are:
• F. Hoffmann-La Roche Ltd.
North America was the largest region in the kedrab market in 2024